Review article: anti TNF‐α induced psoriasis in patients with inflammatory bowel disease

Background  Anti TNF‐α agents are used successfully for several autoimmune diseases, including IBD and psoriasis. An emerging challenge is the increasing incidence of anti TNF‐α induced psoriasis. A total of 120 cases have been currently reported, of whom 18 patients were treated with biological agents for IBD.

[1]  W. Kirch,et al.  Efficacy and tolerability of biologic and nonbiologic systemic treatments for moderate‐to‐severe psoriasis: meta‐analysis of randomized controlled trials , 2008, The British journal of dermatology.

[2]  J. S. Henning,et al.  Psoriatic skin lesions induced by tumor necrosis factor antagonist therapy: a literature review and potential mechanisms of action. , 2008, Arthritis and rheumatism.

[3]  A. Alonso-Ruiz,et al.  Tumor necrosis factor alpha drugs in rheumatoid arthritis: systematic review and metaanalysis of efficacy and safety , 2008, BMC musculoskeletal disorders.

[4]  F. Kerdel,et al.  From conventional to cutting edge: the new era of biologics in treatment of psoriasis , 2008, Dermatologic therapy.

[5]  A. Triantafyllou,et al.  Tumor necrosis factor-a antagonist-induced psoriasis: yet another paradox in medicine , 2008, Clinical Rheumatology.

[6]  P. Tak,et al.  Tumor necrosis factor antagonist mechanisms of action: a comprehensive review. , 2008, Pharmacology & therapeutics.

[7]  P. Gionchetti,et al.  Cutaneous Manifestations in Inflammatory Bowel Diseases: Eight Cases of Psoriasis Induced by Anti-Tumor-Necrosis-Factor Antibody Therapy , 2007, Dermatology.

[8]  R. Caprilli,et al.  Another paradox in Crohn's disease: new onset of psoriasis in a patient receiving tumor necrosis factor-alpha antagonist. , 2007, Inflammatory bowel diseases.

[9]  A. Ishida-Yamamoto,et al.  Psoriasiform and pustular eruption induced by infliximab , 2007, The Journal of dermatology.

[10]  M. Bagot,et al.  Psoriasis induced by tumor necrosis factor-alpha antagonist therapy: a case series. , 2007, The Journal of rheumatology.

[11]  M. Martinka,et al.  Psoriasis and pustular dermatitis triggered by TNF-{alpha} inhibitors in patients with rheumatologic conditions. , 2007, Archives of dermatology.

[12]  U. Kajermo,et al.  Infliximab can precipitate as well as worsen palmoplantar pustulosis: possible linkage to the expression of tumour necrosis factor‐α in the normal palmar eccrine sweat duct? , 2005, The British journal of dermatology.

[13]  F. Nestle,et al.  Defining upstream elements of psoriasis pathogenesis: an emerging role for interferon alpha. , 2005, The Journal of investigative dermatology.

[14]  E. Roé,et al.  Onset of flexural psoriasis during infliximab treatment for Crohn's disease , 2005, Clinical and experimental dermatology.

[15]  K. Çefle,et al.  Two siblings with distal pachydermodactyly , 2005, Clinical and experimental dermatology.

[16]  C. Geisler,et al.  Increased sensitivity to interferon-α in psoriatic T cells , 2005 .

[17]  V. Pascual,et al.  Cross-regulation of TNF and IFN-¿ in autoimmune diseases , 2005 .

[18]  P. Jüni,et al.  Increase of peripheral CXCR3 positive T lymphocytes upon treatment of RA patients with TNF-alpha inhibitors. , 2005, Rheumatology.

[19]  J. Stroehlein,et al.  Pustular psoriasis induced by infliximab. , 2004, Journal of drugs in dermatology : JDD.

[20]  J. Gudjonsson,et al.  Immunopathogenic mechanisms in psoriasis , 2004, Clinical and experimental immunology.

[21]  E. Fonseca,et al.  Psoriasiform Eruption Induced by Infliximab , 2004, The Annals of pharmacotherapy.

[22]  A. Gottlieb,et al.  Etanercept as monotherapy in patients with psoriasis. , 2003, The New England journal of medicine.

[23]  A. Gröne.  Keratinocytes and cytokines. , 2002, Veterinary immunology and immunopathology.

[24]  A. Zinsmeister,et al.  Etanercept for active Crohn's disease: a randomized, double-blind, placebo-controlled trial. , 2001, Gastroenterology.

[25]  Richard W. Martin,et al.  A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis. , 2000, The New England journal of medicine.

[26]  K. Asadullah,et al.  Inhibition of Keratinocyte Apoptosis by IL-15: A New Parameter in the Pathogenesis of Psoriasis?1 , 2000, The Journal of Immunology.

[27]  M. Diaz,et al.  Role of NF-κB in the Apoptotic-resistant Phenotype of Keratinocytes* , 1999, The Journal of Biological Chemistry.

[28]  B. Nickoloff,et al.  Injection of pre-psoriatic skin with CD4+ T cells induces psoriasis. , 1999, The American journal of pathology.

[29]  C. Enerbäck,et al.  Evidence that HLA-Cw6 determines early onset of psoriasis, obtained using sequence-specific primers (PCR-SSP). , 1997, Acta dermato-venereologica.

[30]  B. Nickoloff,et al.  Dermal injection of immunocytes induces psoriasis. , 1996, The Journal of clinical investigation.

[31]  Irene M. Leigh,et al.  Keratins (Kl6 and Kl7) as markers of keratinocyte hyperproliferation in psoriasis in vivo and in vitro , 1995 .

[32]  Gary R. Grotendorst,et al.  Fibroblast function in psoriatic arthritis. II. Increased expression of beta platelet derived growth factor receptors and increased production of growth factor and cytokines. , 1994, The Journal of rheumatology.

[33]  G. Weinstein,et al.  Cell kinetic basis for pathophysiology of psoriasis. , 1985, The Journal of investigative dermatology.

[34]  S. Gelfant.  On the existence of non‐cycling germinative cells in human epidermis in vivo and cell cycle aspects of psoriasis , 1982, Cell and tissue kinetics.

[35]  G. Haroske,et al.  Tumor Necrosis Factor-α Inhibitor-Induced Psoriasis or Psoriasiform Exanthemata , 2008 .

[36]  G. Haroske,et al.  Tumor necrosis factor-alpha inhibitor-induced psoriasis or psoriasiform exanthemata: first 120 cases from the literature including a series of six new patients. , 2008, American journal of clinical dermatology.

[37]  S. Berney.  Psoriasis Induced by Tumor Necrosis Factor-α Antagonist Therapy: A Case Series , 2008 .

[38]  M. Diaz,et al.  Role of NF-kappaB in the apoptotic-resistant phenotype of keratinocytes. , 1999, The Journal of biological chemistry.

[39]  H. E. Hansen,et al.  Psoriasis in monozygotic twins: variations in expression in individuals with identical genetic constitution. , 1982, Acta dermato-venereologica.

[40]  W. Eyler,et al.  PSORIATIC ARTHRITIS. , 1965, Henry Ford Hospital medical bulletin.